Cleveland Biolabs, Inc. (CBLI) Post Smaller Than Expected Q3 Loss
Tweet Send to a Friend
Cleveland Biolabs, Inc. (NASDAQ: CBLI) reported Q3 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
